↓ Skip to main content

Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19—Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)

Overview of attention for article published in Frontiers in Pharmacology, July 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19—Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)
Published in
Frontiers in Pharmacology, July 2022
DOI 10.3389/fphar.2022.870493
Pubmed ID
Authors

M. Karolyi, E. Pawelka, S. Omid, F. Koenig, V. Kauer, B. Rumpf, W. Hoepler, A. Kuran, H. Laferl, T. Seitz, M. Traugott, V. Rathkolb, M. Mueller, A. Abrahamowicz, C. Schoergenhofer, M. Hecking, A. Assinger, C. Wenisch, M. Zeitlinger, B. Jilma, A. Zoufaly

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 3 18%
Student > Master 2 12%
Student > Ph. D. Student 1 6%
Researcher 1 6%
Student > Bachelor 1 6%
Other 2 12%
Unknown 7 41%
Readers by discipline Count As %
Medicine and Dentistry 5 29%
Unspecified 1 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Environmental Science 1 6%
Nursing and Health Professions 1 6%
Other 1 6%
Unknown 7 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2023.
All research outputs
#14,988,355
of 23,971,024 outputs
Outputs from Frontiers in Pharmacology
#5,102
of 17,641 outputs
Outputs of similar age
#207,455
of 436,898 outputs
Outputs of similar age from Frontiers in Pharmacology
#269
of 1,309 outputs
Altmetric has tracked 23,971,024 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,641 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,898 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,309 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.